This journal uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process.
To facilitate this, authors need to ensure that their manuscripts are prepared in a way that does not give away their identity. To help with this preparation please ensure the following when submitting: Please submit the Title Page containing the Authors details and Blinded Manuscript with no author details as 2 separate files. This should include the title, authors' names and affiliations, and a complete address for the corresponding author including e-mail address.

Preliminary evaluation.
All manuscripts submitted for publication must go through the review process. All manuscripts are initially treated by editors to assess their compliance with the requirements of the journal and the subject. Incomplete packages or manuscripts not prepared in the advised style will be sent back to author(s) with suggestions for correction. The authors are notified with the reference number upon manuscript registration at the Editorial Office.
The Editor-in-Chief or Editor reads every manuscript received and assigns a general priority level:
(a) manuscripts sent to reviewers immediately;
(b) manuscripts returned to authors with suggestions for the correction of data presentation;
and (c) rejected manuscripts.
Editors read the revised manuscript. If the manuscript is improved adequately, it is sent to two (or more) reviewers for review and to the Statistical Editor, if it contains numerical data. The preliminary evaluation process usually takes 3 weeks.

Authorship Statement.
Journal does not require authors of original (primary) research papers to assign the copyright of their published contributions (see Copyright Notice). Authors grant Journal an exclusive licence( ICMJE - Exclusive licences ) to publish, in return for which they can reuse their papers in their future printed work without first requiring permission from the publisher of the journal.

Upon acceptance of an article, authors will be asked to complete a “ Conflict of interest declaration and author agreement form”. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a “Conflict of interest declaration and author agreement form”.

All Open Access articles distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Conflict of interests.
Authors should disclose at the time of submission any financial arrangement they may have. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be communicated to the reader. Because the essence of reviews and editorials is selection and interpretation of the literature, journal expects that authors of such articles will not have any financial interest in a company (or its competitor) that makes a product discussed in the article. Journal policy requires that reviewers, associate editors, editors reveal in a letter to the Editor-in-Chief any relationships that they have that could be construed as causing a conflict of interest with regard to a manuscript under review. The letter should include a statement of any financial relationships with commercial companies involved with a product under study.

List of Reviewers:
The following scholars have generously reviewed manuscripts journal and deserve the thanks from all associated with the journal:
2013; 2014; 2015; 2016; 2017 2018


Drawing up the items of the publication policy of the journal Editors followed the recommendations of:
- Elsevier publisher (Double-Blind Peer Review Guidelines);
- Committee on Publication Ethics (COPE) (download PDF);
- International Committee of Medical Journal Editors (ICMJE).